首页
订购/客服:400-666-5481

Voruciclib hydrochloride

    
10mM in DMSO

源叶(MedMol)
V56900 一键复制产品信息
1000023-05-1
C22H20Cl2F3NO5
506.30
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V56900-1ml
10mM in DMSO

¥3700.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Voruciclib hydrochloride is an orally active and selective CDK inhibitor with Ki values of 0.626 nM-9.1 nM. Voruciclib hydrochloride potently blocks CDK9, the transcriptional regulator of MCL-1. Voruciclib hydrochloride represses expression of MCL-1 in multiple models of diffuse large B-cell lymphoma (DLBCL).
靶点: CDK9/CycT1:1.68 nM (Ki); CDK9/cyc T2:0.626 nM (Ki); CDK6/cycD1:2.92 nM (Ki); CDK4/Cyc D1:3.96 nM (Ki); CDK1/cycB:5.4 nM (Ki); CDK1/cyc A:9.1 nM (Ki)
体外研究: Combination of Voruciclib hydrochloride (200 mpk; Oral gavage) and Venetoclax (10 mpk, 1 mpk, 50 mpk, 25 mpk in U2932, RIVA, SU-DHL-4 and NU-DHL-1, respectively) leads to enhance tumor growth inhibition compared to either drug alone in U2932, RIVA, SU-DHL-4 (six days per week for 4 weeks), and NU-DHL-1 models (five days per week for 3 weeks) of DLBCL[1].
体内研究: Voruciclib hydrochloride (0.5-5 µM; 6 hours) shows targeted downregulation of MCL-1 in both ABC and GCB subtypes.
Ki values for each target such as CDK9/cyc T2, CDK9/cyc T1, CDK6/cyc D1, CDK4/cyc D1, CDK1/cyc B, and CDK1/cyc A for Voruciclib hydrochloride are 0.626 nM, 1.68 nM, 2.92 nM, 3.96 nM, 5.4 nM, 9.1 nM, respectively.
参考文献: 1. Dey J, et al. Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition. Sci Rep. 2017 Dec 21;7(1):18007.
 
保存条件: -80°C 12个月; -20°C 6个月, 干燥
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.975 ml 9.876 ml 19.751 ml
5 mM 0.395 ml 1.975 ml 3.95 ml
10 mM 0.198 ml 0.988 ml 1.975 ml
50 mM 0.04 ml 0.198 ml 0.395 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×